portacaval shunt

1. Long-term therapeutic effect of portacaval shunt in treatment of advanced schistosomiasis The causes and management of fever after splenectomy with advanced schistosomiasis
   晚期血吸虫病脾静脉-下腔静脉分流术远期效果晚期血吸虫病脾切除术后发热原因探讨及处理
2. A clinical study on side-to-side portacaval shunt plus enhancement of perfusion of hepatic artery
   附加限制环的限制性门腔静脉侧侧分流加肝动脉强化灌注术的临床研究
3. Evaluation of portal vein pressure by radionuclide imaging in cirrhotic patients undergoing portacaval shunt or pericardial devascularization
   用放射性核素显像方法测定分流和断流术前后门静脉压力及其临床价值
4. Effects of portacaval shunt on gastric mucosa in cirrhotic portal hypertension in rats
   门腔静脉分流术对肝硬变门静脉高压大鼠胃粘膜的影响
5. Small-diameter H-graft portacaval shunt in the treatment of portal hypertension
   小口径人造血管门腔静脉H型分流治疗门静脉高压症
6. Establishment of Direct Intrahepatic Portacaval Shunt in Swine
   猪体内直接性门腔分流的建立
7. Methods Forty portal hypertensive patients ( all in Child A) were divided randomly to two groups after performing limited side to side portacaval shunt: Group Hepa received PN with Hepa amino acid solution and Group Vamin received PN with Vamin amino acid solution as the nitrogen source.
   方法因门脉高压症住院接受脾切除、限制性门腔静脉侧侧分流术的40例肝功能ChildA级患者，随机分为两组：Hepa组和Vamin组，每组各20例。
8. The Limited Side-to-side Portacaval Shunt
   限制性门腔静脉侧侧分流术临床研究
9. Objective To evaluate the clinical value of creating direct intrahepatic portacaval shunt ( DIPS) between retrohepatic segment of inferior vena cava ( RHSIVC) and portal vein.
   目的探讨在肝后段下腔静脉（RHSIVC）与肝内门静脉之间建立直接性肝内门腔分流（DIPS）的临床应用价值。
10. Of 30 cases ( 13.3%) received portacaval shunt ( PCS).
    4例（13.3%）曾接受门腔静脉分流术；
11. Part One: Direct intrahepatic portacaval shunt: the experimental studyPurpose: To determine the safety and feasibility of creating direct intrahepatic portacaval shunt ( DIPS) in swine with puncture under transcutaneous ultrasound guidance.
    第一部分：直接性门腔分流的实验研究目的：探讨采用体表超声引导穿刺，在猪体内建立直接性门腔分流（DIPS）的安全性及可行性。
12. Conclusion: The over-activated lipid peroxide reaction may be one of the important factors which induce hepatic ischemia damage after portacaval shunt. Combined use of ligustrazine and coenzyme Q10 can enhance the protective effects on hepatic ischemia damage.
    结论：体内过度激活的脂质过氧化反应是分流术后肝缺血损害的重要因素之一，联合应用抗氧化剂可增强对肝缺血损害的保护作用。
13. DIPS has expanded the indication of interventional portacaval shunt, even in partial patients which TIPS can not be carried out.
    DIPS扩大了介入性门腔分流适应证，使部分难以实施TIPS术的患者也能做介入性门腔分流。
14. Objective: To observe the functional changes of the gastric mucosa in cirrhotic portal hypertension after portacaval shunt ( PCS).
    目的：胃粘膜病变是门脉高压病人上消化道出血的主要原因，而门脉分流术（PCS）又是治疗门静脉高压症的常用术式，本实验旨在观察PCS术后胃粘膜的功能改变。
15. Therapeutic portacaval shunt for portal hypertension ( A report of 34 cases)
    门腔分流术治疗门脉高压症（附34例分析）
16. Direct intrahepatic portacaval shunt: initial results of 6 patients
    六例直接性门腔静脉分流术的初步经验
17. Clinical application of direct intrahepatic portacaval shunt
    直接性肝内门腔分流的临床应用
18. So we suggest that small bore portacaval shunt should be performed simultaneously while esophagogastric devascularization was done for these cirrhotic patients with severe esophageal varices and higher ( more than 3 60kPa), especially with a history of varix bleeding.
    建议对门静脉压＞3.60kPa的重度食道静脉曲张病例，尤其有出血史者，作门奇断流术时宜同时作小口径门腔分流术。
19. Objective To investigate the safety of Ala-GLN-supplemented parenteral nutrition ( PN) and its nutritional support effect and explore its impact on intestinal permeability in patients after portacaval shunt.
    目的探讨门腔分流术后病人给予含丙氨酰谷氨酰胺双肽（AlaGLN）肠外营养（PN）的安全性；观察其营养支持的效果，及对肠道通透性的影响。
20. Objective To assess the patent rate of vessel PTFE graft at type H portacaval shunt; the effect of shunt diameter on hepatopetal blood flow, decompression efficiency and complications.
    目的了解血管移植物PTFE在H型门腔分流道的通畅率，分流口径对向肝血流的影响以及减压效果和并发症。
21. Percutaneous direct intrahepatic portacaval shunt THE ANGIOARCHITECTURE OF SKIN FLAP
    经皮穿刺直接性门腔静脉分流术皮瓣的血管构筑
22. Objective To for improving the perfusion of liver, we designed an operation of portacaval shunt ( PCS) plus enhancement of perfusion of hepatic artery ( EPHA).
    目的门腔分流术严重影响肝脏血循环，为改善术后肝供血，设计并进行了门腔分流加肝动脉强化灌注术的实验研究。

noun

1. shunt that is created surgically between the portal vein and the inferior vena cava so that blood from the abdominal organs can bypass the liver